Ali Behbahani - Jan 15, 2024 Form 4 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Director
Signature
/s/ Stephanie Brecher, attorney-in-fact
Stock symbol
ADAP
Transactions as of
Jan 15, 2024
Transactions value $
$0
Form type
4
Date filed
1/17/2024, 05:06 PM
Previous filing
Dec 21, 2023
Next filing
Apr 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADAP Option to purchase Ordinary Shares Award $0 +41K $0.00 41K Jan 15, 2024 Ordinary Shares 41K $0.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price was converted from GBP0.11 based on an exchange rate of U.S.$1.274570 to GBP1.00. The actual exercise price will be the pounds sterling amount.